Concepedia

G I Rodriguez

GI

Statistics

Publications

11

Citations

1.5K

H-Index

11

Active since

1993

Affiliations

The University of Texas Health Science Center at San Antonio(Current)

Rotterdam University of Applied Sciences

Brooke Army Medical Center

G I Rodriguez is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, oncology, and pharmacology.

Top concepts

Publications per year

1993–2001

11

Publications

11

A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer.

Ian Ganly, David H. Kirn, Gail Eckhardt et al. · PubMed · 2000 · 439 citations

, , +16

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.

Mace L. Rothenberg, John R. Eckardt, John G. Kuhn et al. · Journal of Clinical Oncology · 1996 · 351 citations

Phase I and pharmacokinetic trial of weekly CPT-11.

Mace L. Rothenberg, John G. Kuhn, Howard A. Burris et al. · Journal of Clinical Oncology · 1993 · 301 citations

, , +13

Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors.

G.J. Creemers, C J Gerrits, John R. Eckardt et al. · Journal of Clinical Oncology · 1997 · 75 citations

A comparison of clinical pharmacodynamics of different administration schedules of oral topotecan (Hycamtin)

C J Gerrits, Jan H.M. Schellens, Howard A. Burris et al. · PubMed · 1999 · 65 citations

, , +17

1–5 of 11